Literature DB >> 8510390

Forty-five year follow-up after uninephrectomy.

D M Narkun-Burgess1, C R Nolan, J E Norman, W F Page, P L Miller, T W Meyer.   

Abstract

This study examined the consequences of nephrectomy in United States Army personnel who lost a kidney due to trauma during World War II (WWII). Records of 62 servicemen who underwent nephrectomy at an average age of 25 years were obtained. Mortality was compared with that of WWII servicemen of the same age. Medical records of 28 deceased subjects were reviewed for evidence of kidney disease. Medical histories were obtained and blood pressure and kidney function were assessed in 28 living subjects. Two subjects could not be located, and four subjects declined to participate. Mortality at 45 years was not increased in nephrectomized subjects. Kidney disease present in six of 28 deceased subjects was attributable to causes other than prior nephrectomy. Glomerular sclerosis was not increased in 10 subjects who had autopsy examinations. The prevalence of hypertension was not increased in living subjects. Five of 28 living subjects had abnormal renal function manifested by proteinuria greater than 250 mg/day in four cases (range: 377 to 535 mg/day) and serum creatinine levels greater than 1.5 mg/dl in three cases (range: 1.7 to 1.9 mg/dl). Conditions other than nephrectomy could have contributed to impairment of renal function in each of these subjects. These findings suggest that uninephrectomy in young adults has few major adverse consequences over 45 years.

Entities:  

Mesh:

Year:  1993        PMID: 8510390     DOI: 10.1038/ki.1993.156

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  32 in total

Review 1.  The living kidney donor evaluation: focus on renal issues.

Authors:  Ajay Kher; Didier A Mandelbrot
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-05       Impact factor: 8.237

Review 2.  Intrauterine growth restriction: fetal programming of hypertension and kidney disease.

Authors:  Norma B Ojeda; Daniela Grigore; Barbara T Alexander
Journal:  Adv Chronic Kidney Dis       Date:  2008-04       Impact factor: 3.620

3.  Living donor evaluation and exclusion: the Stanford experience.

Authors:  Jessica B Lapasia; Soo-yee Kong; Stephan Busque; John D Scandling; Glenn M Chertow; Jane C Tan
Journal:  Clin Transplant       Date:  2010-11-02       Impact factor: 2.863

4.  Debate: PRO Position. Formal assessment of donor kidney function should be mandatory.

Authors:  Jane C Tan; Stéphan Busque; Bing Ho; Bryan D Myers
Journal:  Am J Nephrol       Date:  2011-02-18       Impact factor: 3.754

Review 5.  Fetal programming and cardiovascular pathology.

Authors:  Barbara T Alexander; John Henry Dasinger; Suttira Intapad
Journal:  Compr Physiol       Date:  2015-04       Impact factor: 9.090

Review 6.  Living donor practices in the United States.

Authors:  Didier A Mandelbrot; Martha Pavlakis
Journal:  Adv Chronic Kidney Dis       Date:  2012-07       Impact factor: 3.620

Review 7.  Comparison of the laparoscopic versus open live donor nephrectomy: an overview of surgical complications and outcome.

Authors:  H Fonouni; A Mehrabi; M Golriz; M Zeier; B P Müller-Stich; P Schemmer; J Werner
Journal:  Langenbecks Arch Surg       Date:  2014-04-28       Impact factor: 3.445

8.  Long-term consequences of kidney donation.

Authors:  Hassan N Ibrahim; Robert Foley; LiPing Tan; Tyson Rogers; Robert F Bailey; Hongfei Guo; Cynthia R Gross; Arthur J Matas
Journal:  N Engl J Med       Date:  2009-01-29       Impact factor: 91.245

9.  Reduced nephron number in adult sheep, hypertensive as a result of prenatal glucocorticoid treatment.

Authors:  E M Wintour; K M Moritz; K Johnson; S Ricardo; C S Samuel; M Dodic
Journal:  J Physiol       Date:  2003-05-02       Impact factor: 5.182

10.  Renal carcinogenesis after uninephrectomy.

Authors:  Yi Sui; Hai-Lu Zhao; Heung Man Lee; Jing Guan; Lan He; Fernand Mm Lai; Peter Cy Tong; Juliana Cn Chan
Journal:  Transl Oncol       Date:  2009-12       Impact factor: 4.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.